Skip to content

EBITDA at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Amcor logo
AmcorAMCR
Nordson logo
NordsonNDSN
Baxter International logo
Baxter InternationalBAX
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

$107.5Mebit+
$64.3MDepreciation Depletion & Amortization
=$171.81M

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's EBITDA?
AptarGroup (ATR) reported EBITDA of $171.81M in Q1 2026.
How has AptarGroup's EBITDA changed year-over-year?
AptarGroup's EBITDA decreased by 4.1% year-over-year, from $179.1M to $171.81M.
What is the long-term trend for AptarGroup's EBITDA?
Over 4 years (2021 to 2025), AptarGroup's EBITDA has grown at a 6.7% compound annual growth rate (CAGR), from $582.2M to $754.09M.
What does EBITDA mean?
Operating cash profit before interest, taxes, and non-cash charges.
How do you interpret EBITDA?
Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
How does EBITDA compare across companies?
Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.